References
- BaytopT. 1999. Türkiye'de Bitkilerle Tedavi [Therapy with medicinal plants in Turkey]. Istanbul: Nobel Tıp Kitabevi; p. 243.
- BollPM. 1963. Alkaloid glycosides from Solanum dulcamara. Acta Chem Scand. 17:1852–1858.
- BownD. 1995. Encylopaedia of herbs and their uses. London: Dorling Kindersley Press.
- ChevallierA. 1996. The encyclopedia of medicinal plants. London: Darling Kindersley Limited; p. 268.
- DavidB, SackS. 2001. Diabetes. In: Tietz fundementals of clinical chemistry. 5th ed. Philadelphia (PA): W.B. Saunders Company Press; p. 433–435.
- EvansWC. 1996. Trease and evan's pharmacognosy. 14th ed. Edinburgh: W.B. Saunders Company Press; p. 638.
- GrieveM. 2000. A modern herbal. Vol. II. New York (NY): Dover Publications Inc.; p. 589.
- GuytonCA, HallJE. 2000. Textbook of physiology. 10th ed. Philadelphia (PA): W.B. Saunders Company Press; p. 894.
- HarborneJB. 1993. The flavonoids – advances in research since 1986. London: Chapman & Hall.
- HarmandarM, BilaloğluGV. 2009. Flavonoidler. Ankara: Aktif Yayınevi; p. 272–298.
- JadhavR, PuchchakayalaG. 2012. Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin–nicotinamide induced type 2 diabetic rats. Int J Pharm Pharm Sci. 4:251–256.
- KayaalpO. 2012. Akılcı Tedavi Yönünden Tıbbi Farmakoloji [Regarding the rational therapy medical pharmacology]. Ankara: Pelikan Yayınevi; p. 1099.
- KhalilMW, IdlerDR, PattersonGW. 1980. Sterols of scallop. III. Characterization of some C-24 epimeric sterols by high resolution nuclear magnetic resonance spectroscopy. Lipids. 15:69–73.
- KluyV, WrayV, WilluhnG. 1992. Steroidal saponins from Solanum dulcamara. Planta Med. 58:A707–A710.
- KostensJ, WilluhnG. 1972. Die Alkane von Solanum dulcamara L. Arch Pharm. 305:944–949.
- LeeYA, ParkYK, KimYH. 2005. Solanoflavone, a new biflavonol glycoside from Solanum melongena: seeking for anti-inflammatory components. Arch Pharm Res. 28:657–659.
- LorkeD. 1983. A new approach to practical acute toxicity testing. Arch Toxicol. 54:275–287.
- NawwarMAM, El-MousallamyAMD, BarakatHH. 1989. Quercetin 3-glycosides from the leaves of Solanum nigrum. Phytochemistry. 28:1755–1757.
- NwachukwuDC, OkwuosaCN, AchukwuPU, AzubikeN, EzeGE. 2010. Investigation of the anti-hyperglycaemic effect of the leaf extracts of Solanum dulcamara in diabetic rats. Indian J Novel Drug Deliv. 4:138–143.
- OlusolaL, IkeCO, MariamS. 2003. Hyperglycaemic properties of aqueous bark extract of Ceiba pentandra in streptozotocin-induced diabetic rats. J Ethnopharmacol. 84:139–142.
- SabudakT, KhanMTH, ChoudrayMI, OksuzS. 2006. Potent tyrosinase inhibitors from Trifolium balansae. Nat Prod Res. 20:665–670.
- ShapiroK, GongWC. 2002. Natural product used for diabetes. J Am Pharm Assoc. 42:217–226.
- WalkowiakA, TaniocznikB, KowalewskiZ. 1990. Flavonoid compounds from Solanum dulcamara. Herba Pol. 36:133–137.
- WallaceJL. 1999. Management of diabetes in the elderly. Clin Diabetes. 17:1–6.
- WilluhnG, KostensJ. 1975. Die quantitative verteilung der sterine und sterin derivative in organen von Solanum dulcamara. Phytochemistry. 14:2055–2058.
- WilluhnG, MayS, MerfortI. 1982. Triterpene and steroids seeds of Solanum dulcamara. Planta Med. 46:99–104.
- YamashitaT, MatsumotoT, YaharaS, YashidaN, NoharaT. 1991. Structures of two new steroidal glycosides, soladulcosides A and B from Solanum dulcamara. Chem Pharm Bull. 39:1626–1628.